Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation: POTENTIAL FOR TREATING PARKINSON DISEASE

The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (l-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss are oxidative stress, including oxidation of l...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lee, Moonhee, Tazzari, Valerio, Giustarini, Daniela, Rossi, Ranieri, Sparatore, Anna, Del Soldato, Piero, McGeer, Edith, McGeer, Patrick L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Biochemistry and Molecular Biology 2010
Ämnen:
Molecular Bases of Disease
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878495/
https://ncbi.nlm.nih.gov/pubmed/20368333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.115261
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk